Botox for TMJ disorders may not lead to bone loss in the short term, but more research is needed
(New York University) Botox injections to manage jaw and facial pain do not result in clinically significant changes in jaw bone when used short term and in low doses, according to researchers at NYU College of Dentistry. However, they found evidence of bone loss when higher doses were used. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 14, 2020 Category: International Medicine & Public Health Source Type: news

---
OB-GYN Dr. Sujatha Reddy talks about the risk vs. reward of using botox to ease migraines, while pregnant. (Source: CNN.com - Health)
Source: CNN.com - Health - September 8, 2020 Category: Consumer Health News Source Type: news

Novel Botulinum Toxin Type A Earns High Marks for Forehead Lines Novel Botulinum Toxin Type A Earns High Marks for Forehead Lines
When the study is completed, conclusions can be reached about the investigational product's durability of benefit for treatment of dynamic forehead lines, which are notoriously challenging to treat.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - August 21, 2020 Category: Dermatology Tags: Dermatology News Source Type: news

Botox Injections May Ease Depression
MONDAY, Aug. 3, 2020 -- Botox injections, which are commonly used to lessen wrinkles, migraines, muscle spasms, excessive sweating, and incontinence, may also help treat depression, according to a study published online July 30 in Scientific... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 3, 2020 Category: Pharmaceuticals Source Type: news

Could Botox Injections Relieve Depression?
Title: Could Botox Injections Relieve Depression?Category: Health NewsCreated: 7/30/2020 12:00:00 AMLast Editorial Review: 7/31/2020 12:00:00 AM (Source: MedicineNet Depression General)
Source: MedicineNet Depression General - July 31, 2020 Category: Psychiatry Source Type: news

Could Botox Injections Relieve Depression?
THURSDAY, July 30, 2020 -- Botox injections used to fight wrinkles and prevent migraines may also help relieve depression, a new study suggests. Patients who received Botox injections for any of six conditions reported suffering depression 40% to... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 30, 2020 Category: General Medicine Source Type: news

Botox could ease depression in addition to wrinkles, study finds
Botox injections may do more than erase the signs of age, or prevent you from feeling painful migraines — they may alleviate depression as well, a new study confirms. (Source: CNN.com - Health)
Source: CNN.com - Health - July 30, 2020 Category: Consumer Health News Source Type: news

Headline news: Botox injections may lessen depression
(University of California - San Diego) By analyzing the FDA database of adverse drug effects, UC San Diego researchers discovered that people who received Botox injections -- not just in the forehead -- reported depression significantly less often than patients undergoing different treatments for the same conditions. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 30, 2020 Category: International Medicine & Public Health Source Type: news

FDA Approves Expanded Botox (onabotulinumtoxinA) Label for the Treatment of Pediatric Patients with Spasticity
NORTH CHICAGO, Ill., July 9, 2020 /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, today announced that the U.S. Food and Drug Administration (FDA) approved a supplemental Biologics License Application (sBLA) that supports expanded use of... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 9, 2020 Category: Drugs & Pharmacology Source Type: news

FDA Accepts Supplemental Biologics License Application (sBLA) for BOTOX(R) (onabotulinumtoxinA) for the Treatment of Pediatric Patients with Neurogenic Detrusor Overactivity
Application Seeks to Extend Use of BOTOX® for Patients 5 to 17 Years Old NORTH CHICAGO, Ill., June 22, 2020 -- (Healthcare Sales & Marketing Network) -- Allergan, an AbbVie (NYSE: ABBV) company, today announced that the U.S. Food and Drug Administr... Biopharmaceuticals, Neurology, FDA Allergan, AbbVie, BOTOX, onabotulinumtoxinA, Neurogenic Detrusor Overactivity (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 22, 2020 Category: Pharmaceuticals Source Type: news

Adding CGRP to Botox Safe, Effective for Migraine Prevention Adding CGRP to Botox Safe, Effective for Migraine Prevention
Adjunctive preventive therapy with a calcitonin gene-related peptide monoclonal antibody is safe and effective in patients with chronic migraine who have only achieved a partial response to onabotulinumtoxinA treatment.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - June 18, 2020 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Anti-CGRP mABs and Botulinum Toxin for Migraine Prevention Anti-CGRP mABs and Botulinum Toxin for Migraine Prevention
This article presents a pathophysiological rationale for dual therapy with anti-CGRP humanized antibodies and botulinum toxin type A in the prevention of migraine.Headache (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 16, 2020 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Florida offers drive-through Botox to quarantined residents
Quarantined Florida residents worried about their laughter lines and crows' feet need frown no longer - Botox is back, and it's being offered at a drive-through. (Source: Reuters: Health)
Source: Reuters: Health - June 4, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

From botox clinics to wellness spas, antibody tests become the rage. Are they the real thing?
Coronavirus: Experts warn of misplaced trust in antibody tests (Source: L.A. Times - Health)
Source: L.A. Times - Health - May 12, 2020 Category: Consumer Health News Authors: Maya Lau Source Type: news

US regulator clears AbbVie’s $63bn deal for Allergan
Federal Trade Commission votes 3-2 to approve tie-up between makers of Botox and Humira (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 6, 2020 Category: Pharmaceuticals Source Type: news

Building a better botox
(Boston Children's Hospital) Botulinum toxins are FDA-approved and widely used. Although they are safe and effective, they can drift away from the site of injection, reducing efficacy and causing side effects. New work from Boston Children's Hospital on botulinum B combined structural modeling and genetic engineering to enable the toxin to bind more tightly to nerve cells and stay in place. This led to more effective, longer-lasting local muscle paralysis and reduced toxicity. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 17, 2020 Category: International Medicine & Public Health Source Type: news

Botox: A New Option for Endometriosis Pain? Botox: A New Option for Endometriosis Pain?
Botulinum toxin injections into the vagina appears to relieve pain associated with endometriosis by relaxing the pelvic floor muscles, new research suggests.Medscape Medical News (Source: Medscape ObGyn and Womens Health Headlines)
Source: Medscape ObGyn and Womens Health Headlines - March 9, 2020 Category: OBGYN Tags: Neurology & Neurosurgery News Source Type: news

Unlicensed injections recorded at undercover Botox party sting: Doctors college
B.C.'s College of Physicians and Surgeons claims an undercover sting at a Botox party has yielded evidence of unlicensed injections administered by a woman who has been a repeated target of the regulator. (Source: CBC | Health)
Source: CBC | Health - March 4, 2020 Category: Consumer Health News Tags: News/Canada/British Columbia Source Type: news

Try Botox jabs to ease teeth grinding at night: Dr Martin Scurr answers your health questions 
The Daily Mail's resident doctor Martin Scurr answers your health concerns in his column. This week a reader asks if the ringing in their ears is connected to them clenching their teeth. (Source: the Mail online | Health)
Source: the Mail online | Health - January 21, 2020 Category: Consumer Health News Source Type: news

EU Clears AbbVie Takeover of Allergan Subject to Conditions EU Clears AbbVie Takeover of Allergan Subject to Conditions
The European Commission said on Friday it had approved U.S. drugmaker AbbVie's planned $63 billion acquisition of Botox-maker Allergan, subject to conditions.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 13, 2020 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

GP slams 'Wild West' approach to Botox - after Love Island star 'qualifies' to give treatments
Rykard Jenkins has been sharing his experience of training to become an aesthetic practitioner. However, one aesthetic doctor has criticised companies offering such training to non medics. (Source: the Mail online | Health)
Source: the Mail online | Health - November 22, 2019 Category: Consumer Health News Source Type: news

Allergan(R) Announces First Annual National BOTOX(R) Cosmetic (onabotulinumtoxinA) Day
IT'S BO-TIME: BRAND CELEBRATES HOLIDAY WITH EXCLUSIVE ONE-DAY-ONLY OFFER DUBLIN, Nov. 18, 2019 -- (Healthcare Sales & Marketing Network) -- Allergan plc (NYSE: AGN), the maker of BOTOX® Cosmetic, has announced the first-ever National BOTOX® Cos... Biopharmaceuticals, Dermatology Allergan, BOTOX, onabotulinumtoxinA (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 18, 2019 Category: Pharmaceuticals Source Type: news

Why women in their 40s are seeking full-on facelifts instead of botox
Civil servant Mel Beard, 49, from West Sussex, pictured left before her facelift and right after the procedure said she considered going under the knife five years earlier. (Source: the Mail online | Health)
Source: the Mail online | Health - November 16, 2019 Category: Consumer Health News Source Type: news

Allergan's Botox gets pediatric approval
Allergan announced that the U.S. FDA has approved the company's supplemental BLA for Botox for the treatment of pediatric patients (2 to 17 years of age) with lower limb spasticity, excluding spasticity caused by cerebral palsy. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - October 25, 2019 Category: Pharmaceuticals Source Type: news

FDA Approves Botox (onabotulinumtoxinA) for Pediatric Patients with Lower Limb Spasticity, Excluding Spasticity Caused by Cerebral Palsy
DUBLIN, Oct. 24, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) approved the company's supplemental Biologics License Application (sBLA) for Botox for the treatment of pediatric... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 25, 2019 Category: Drugs & Pharmacology Source Type: news

FDA Approves Botox for Lower-Limb Spasticity in Children FDA Approves Botox for Lower-Limb Spasticity in Children
The FDA has approved Botox to ease lower-limb spasticity in children and adolescents aged 2 to 17 years, excluding spasticity caused by cerebral palsy.FDA Approvals (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - October 24, 2019 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news

FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Lower Limb Spasticity, Excluding Spasticity Caused by Cerebral Palsy
Approval Marks 11th BOTOX® Therapeutic Indication and Comes 30 Years After the First Indications Were Approved DUBLIN, Oct. 24, 2019 -- (Healthcare Sales & Marketing Network) -- Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug A... Biopharmaceuticals, FDA Allergan, BOTOX, onabotulinumtoxinA, limb spasticity (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 24, 2019 Category: Pharmaceuticals Source Type: news

Fort Washington Man Sentenced to 66 Months in Federal Prison for Two Separate Drug Cases
Daniel Mark Wilkerson, Ft. Washington MD, prescription drugs, federal military hospitals, Rodger Gurdon, Issa Wasco Koroma, Norditropon, Humatrope, Somatotropin, Botox, human growth hormone, pharmacies, Ft. Belvoir Community Hospital VA, Walter Reed National Military Medical Center, Bethesda MD, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - October 7, 2019 Category: Medical Law Authors: DOJ Source Type: news

Botox bars raise concern among medical experts and patients
Nearly 16 million minimally invasive cosmetic procedures took place last year in the U.S. That includes nearly 7.5 million botox, and other neurotoxin injections to reduce wrinkles as well as 2.5 million filler injections to shape the face. These enhancements traditionally require a visit to a doctor's office but as Dr. Tara Narula shows us, new salons are offering injections in a more casual setting -- creating potential risks. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 2, 2019 Category: Consumer Health News Source Type: news

Botox bars raise concern among medical experts: "Things can happen"
New salons are offering the procedure in a more casual setting – but experts say there's risks (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 2, 2019 Category: Consumer Health News Source Type: news

Patients who bought a doctor’s Botox services on Groupon got phony injections, officials say
Authorities raided her Coral Springs, Fla., office earlier this week as part of a year-long investigation into her practices, local news reports say. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - September 14, 2019 Category: Consumer Health News Authors: Hannah Knowles Source Type: news

Evolus Says Launch of Its Botox Rival Ahead of Its Expectations Evolus Says Launch of Its Botox Rival Ahead of Its Expectations
Evolus Inc on Monday reported revenue of $2.3 million from early sales of its newly launched rival to Allergan Plc's Botox, ahead of its own expectations.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 14, 2019 Category: Consumer Health News Tags: Plastic Surgery & Aesthetic Medicine News Source Type: news

JPMorgan set to scoop record fee for Allergan sale
AbbVie’s planned $63bn purchase of the Botox-maker will earn $123m for bank (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - August 13, 2019 Category: Pharmaceuticals Source Type: news

Botox less costly but more AEs than neuromodulation
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - August 1, 2019 Category: Drugs & Pharmacology Source Type: news

'Dr. Lipjob' sent to jail for illegally injecting Botox
The Abbotsford woman who calls herself "Dr. Lipjob" has been sent to jail after defying a court order to stop injecting Botox and dermal fillers. (Source: CBC | Health)
Source: CBC | Health - July 30, 2019 Category: Consumer Health News Tags: News/Canada/British Columbia Source Type: news

The Takeaway: This dentist is filling cavities and offering botox treatments
Dr. Javod Gol at Precision Dentistry officially started offering cosmetic facial treatments in 2017 and has seen 20 percent growth in that area every year since. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 24, 2019 Category: Biotechnology Authors: Jessica Iannetta Source Type: news

Botox cousin can reduce malaria in an environmentally friendly way
(Stockholm University) Researchers at the universities in Stockholm and Lund, in collaboration with researchers from the University of California, have found a new toxin that selectively targets mosquitos. This can lead to innovative and environmentally friendly approaches to reduce malaria. The results are presented in an article published in Nature Communications. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 28, 2019 Category: International Medicine & Public Health Source Type: news

Study finds selfie filters are driving young people to Botox
Researchers at Johns Hopkins show there is reason to be concerned that people may be driven to edit their own faces because they feel inadequate compared to filtered faces. (Source: the Mail online | Health)
Source: the Mail online | Health - June 27, 2019 Category: Consumer Health News Source Type: news

AbbVie takes a $63bn Botox injection
Welcome to Due Diligence, the FT’s daily deals briefing (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - June 26, 2019 Category: Pharmaceuticals Source Type: news

AbbVie has firm hopes for Botox-maker Allergan
Pipeline failures and drugs coming off patent lead to tie-up of pharma companies (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - June 26, 2019 Category: Pharmaceuticals Source Type: news

AbbVie to buy Botox maker Allergan for $63 billion
The acquisition aims to diversify AbbVie beyond its top-selling drug Humira, which will soon lose patent protection (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - June 25, 2019 Category: Consumer Health News Source Type: news

AbbVie buying Botox maker Allergan in $63B deal
AbbVie Inc. said it's buying Dublin, Ireland-based drug firm Allergan in a $63 billion deal. AbbVie (NYSE: ABBV), based in North Chicago, Illinois, said it's paying 0.8660 of its shares and $120.30 in cash for each Allergan (NYSE: AGN) share, for a total consideration of $188.24 per Allergan share. AbbVie said the combined companies' headquarters will remain in North Chicago. "This is a transformational transaction for both companies and achieves unique and complementary strategic objectives.… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 25, 2019 Category: Pharmaceuticals Authors: Ben Miller Source Type: news

AbbVie to acquire Botox maker Allergan for $63bn
Cash and stock offer marks latest blockbuster deal in healthcare sector (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - June 25, 2019 Category: Pharmaceuticals Source Type: news

Botox Maker Allergan Is Sold to AbbVie in $63 Billion Deal
The transaction would give AbbVie a potent source of popular treatments as it faces the loss of patent protection for its best-selling drug, Humira. (Source: NYT Health)
Source: NYT Health - June 25, 2019 Category: Consumer Health News Authors: Michael J. de la Merced Tags: Allergan Inc Mergers, Acquisitions and Divestitures Drugs (Pharmaceuticals) AbbVie Inc Botox (Drug) Source Type: news

FDA OKs Botox for Upper Limb Spasticity in Children FDA OKs Botox for Upper Limb Spasticity in Children
Botox is the first neurotoxin to be approved in the US to treat upper limb spasticity for pediatric patients aged 2 years and older.FDA Approvals (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - June 24, 2019 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news

A Year After Approval, Migraine Drugs Are Changing Lives. But Insurance Battles Are Creating a Whole New Headache
Last May, the Food and Drug Administration (FDA) approved Amgen and Novartis’ Aimovig, the first drug specifically designed to prevent chronic migraines, and offered new hope to the millions of Americans regularly weathering these debilitating headaches. Just months later came two other drugs in its class, Eli Lilly’s Emgality and Teva Pharmaceuticals’ Ajovy. About a year after Aimovig hit the market, patients and doctors are reporting dramatic successes thanks to these therapies. But as insurance horror stories accumulate, and manufacturer-sponsored financial assistance programs approach their end, patie...
Source: TIME: Health - June 24, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Drugs Source Type: news

FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
BOTOX® is the First Neurotoxin Treatment Approved to Treat Pediatric Patients, 2 to 17 Years of Age, with Upper Limb Spasticity Approval Marks 10th BOTOX® Therapeutic Indication in its 30th Anniversary Year DUBLIN, June 21, 2019 -- (Healthcar... Biopharmaceuticals, FDA Allergan, BOTOX, onabotulinumtoxinA, limb spasticity (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 21, 2019 Category: Pharmaceuticals Source Type: news

FDA Approves Botox (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
DUBLIN, June 21, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) approved the company's supplemental biologics application (sBLA) for Botox for the treatment of pediatric patients (2 to... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 21, 2019 Category: Drugs & Pharmacology Source Type: news

Botox May Help Bipolar Depression, Social Anxiety Botox May Help Bipolar Depression, Social Anxiety
In two small case series, injections of botulinum toxin into the glabellar region -- the area between the eyebrows and above the nose -- reduced symptoms of bipolar depression and social anxiety.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - May 30, 2019 Category: Psychiatry Tags: Psychiatry News Source Type: news

April 4, 2018: Canadian Pharmacist Sentenced for Distributing Counterfeit and Adulterated Botox to Local Doctors
(Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - May 16, 2019 Category: Medical Law Authors: u.s. Department of Justice Source Type: news